Hiroya Kawai

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Utility of Right Ventricular Free Wall Speckle-Tracking Strain for Evaluation of Right Ventricular Performance in Patients with Pulmonary Hypertension

Yuko Fukuda, Hidekazu Tanaka, Daisuke Sugiyama et al. · Journal of the American Society of Echocardiography · 2011 · 187 citations

Hypertension, Heart Failure, Pulmonary Arterial Hypertension +10

Efficacy of Right Ventricular Free-Wall Longitudinal Speckle-Tracking Strain for Predicting Long-Term Outcome in Patients With Pulmonary Hypertension

Yoshiki Motoji, Hidekazu Tanaka, Yuko Fukuda et al. · Circulation Journal · 2012 · 115 citations · Full text

<b>MR Angiography with Sensitivity Encoding (SENSE) for Suspected Pulmonary Embolism:</b> Comparison with MDCT and Ventilation–Perfusion Scintigraphy

Yoshiharu Ohno, Takanori Higashino, Daisuke Takenaka et al. · American Journal of Roentgenology · 2004 · 108 citations

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

Takahiro Sawada, Hideo Tsubata, Naoko Hashimoto et al. · Cardiovascular Diabetology · 2016 · 101 citations · Full text